Table 1. Mean prevalence of antibodies to Leptospira serogroups in people in cross-sectional studies; in febrile patients; in rodents; in cattle in Tanzania in leptospirosis papers published 1997–2021.
| Study type, number and references | Seroprevalence (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Australis | Ballum | Djasiman | Grippotyphosa | Hebdomadis | Icterohaemorrhagiae | Sejroe | Tarassovi | |
| Cross-sectional studies in people (n = 5) [15,26,31–33] | 3.43 | 0.48 | NT | 1.58 | 1.50 | 5.38 | 9.35 | 1.00 |
| Hospital based studies in febrile patients (n = 4) [21,27,29,34] | 20.48 | 5.78 | 16.20 | 8.20 | 6.13 | 17.45 | 4.18 | 7.4 |
| Cross sectional studies in rodents (n = 7) [11,15,31,35–38] | 8.38 | 1.47 | NT | 2.07 | 0.28 | 7.29 | 0.37 | NT |
| Cross sectional studies in cattle (n = 6) [11,15,39–41] | 0.80 | 0.00 | NT | 4.80 | 5.10 | 4.25 | 15.94 | 15.10 |
NT—Not tested